TENX compared with DBVT: revenue, margins and what each company keeps, and the suppliers and customers both name

TENXTenax Therapeutics, Inc.

Mkt capRevenueRevenue

DBVTDBV Technologies S.A.

Mkt capRevenueRevenue

Compare

TENXTenax Therapeutics, Inc.

DBVTDBV Technologies S.A.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

TENX1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−9.27%—

DBVT1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26thin chain±43.1%▼−3.38%×0.08

= impliedTENX realized, solidDBVT realized, hatchedOne scale, both sides: full bar = 44%× = |realized| ÷ impliedSource: market data

TENXTenax Therapeutics, Inc.

1.80· pre 1.81· delayed

Mkt cap$67.4MRevenue—Revenue—

DBVTDBV Technologies S.A.

9.02· pre 9.02· delayed

Pre-marketNov 3 '26delayed

Mkt cap$569.0MRevenue$2MQ3 FY26Revenue$6MFY25

Compare

Pre-marketNov 3 '26delayed

TENXTenax Therapeutics, Inc.

DBVTDBV Technologies S.A.

1.80pre 1.81delayed

Price

9.02pre 9.02delayed

$67.4M

Mkt cap

$569.0M

—

Revenue

$2MQ3 FY26

—

Revenue

$6MFY25

TENX1.80vsDBVT9.02Pre-marketNov 3 '26delayed